DEF 14A: Ensign Group Seeks Stockholder Approval for Board Expansion, Executive Pay, and Accounting Firm Ratification

The Ensign Group is holding its 2024 Annual Meeting of Stockholders to vote on key proposals including increasing the board size, approving executive compensation, and ratifying the appointment of Deloitte & Touche LLP as the independent accounting firm.

Summary

• The Ensign Group, Inc. is soliciting proxies for its 2024 Annual Meeting of Stockholders to be held on May 16, 2024.
• Key proposals include the election of two Class II directors, Christopher R. Christensen and Daren J. Shaw, for a three-year term expiring in 2027.
• Stockholders will also vote on an amendment to the Certificate of Incorporation to increase the board size from eight to nine directors.
• The ratification of Deloitte & Touche LLP as the independent registered public accounting firm for 2024 is also on the agenda.
• An advisory vote on the company's named executive officer compensation is included.
• The Board recommends voting FOR all proposals.
• In 2023, Ensign's consolidated revenue reached an all-time high, increasing by 23.3% compared to the previous year.
• Over the past five years, the company has achieved a 16.3% compound annual growth rate (CAGR) in total revenue and a 27.4% CAGR in diluted EPS.
• The company generated $376.7 million in cash flow from operations in 2023.
• The company's same-facility occupancy rate was 79.9% at the end of 2023.
• The company's mean score on the Five-Star Quality Rating System is 65.4%, which exceeds the national average score of 57.2%.

Sentiment

Score: 8

Explanation: The document presents a positive outlook with strong financial performance and strategic initiatives. While it acknowledges challenges, the overall tone is optimistic and forward-looking.

Positives

• Consolidated revenue reached an all-time high, up 23.3% compared to last year.
• The company has achieved a 16.3% compound annual growth rate (CAGR) in total revenue and a 27.4% CAGR in diluted EPS over the last five years.
• The company generated $376.7 million in cash flow from operations in 2023.
• Same-facility occupancy rate was 79.9% at the end of 2023.
• Third-party nursing agencies usage declined from prior year, representing a reduction in agency usage of 58% since its peak in December 2022.
• The company's mean score on the Five-Star Quality Rating System is 65.4%, which exceeds the national average score of 57.2%.

Risks

• The document mentions cybersecurity risks associated with the use of information technology, including system disruption, security breaches, and data theft.
• The document mentions a civil case settlement of $48.0 million.

Future Outlook

When we consider the current health of our organization, combined with our culture and proven local leadership strategy, we are well-positioned to have another outstanding year in 2024.

Management Comments

• As 2023 progressed, our company maintained strong momentum on our mission to dignify post-acute care in the eyes of the world.
• Caregivers in our independent operations are dedicated to creating an atmosphere where residents and their families feel loved, informed and comfortable, while providing a high level of care.
• Our efforts and leadership have continued to foster patient care and professional competence at our independent subsidiaries and set a new industry standard for each patient we serve.
• Our 2023 and ongoing success is largely driven by our proven ability to build strong relationships with key stakeholders in local healthcare communities, in part, by leveraging our reputation for providing superior care.
• Accordingly, our unique organizational structure promotes the empowerment of local leadership and caregivers to make their independent operations the operation of choice in their communities.
• This is accomplished by allowing local leadership to discern and address the unique needs and priorities of healthcare professionals, customers and other stakeholders in the local community or market, and then work to create a superior service offering for, and reputation in, their particular community.
• We are very proud by what we were able to accomplish in 2023 while dealing with so many unusual challenges that arose from the post-COVID environment and regulations, but we also know there is room for improvement and are excited about the enormous potential within our portfolio as we continue to apply our proven locally-driven healthcare model.

Industry Context

The document references several companies in the skilled nursing and related industries, including National Healthcare Corporation, Amedisys, Inc., Encompass Healthcare Corp., LTC Properties, Inc., Omega Healthcare Investors, Inc., Welltower Inc., Select Medical Holdings Corp., CareTrust REIT Inc., and National Health Investors, Inc., for benchmarking director and executive compensation.

Comparison to Industry Standards

• The Compensation Committee reviews the published director compensation information of other healthcare and real estate investment trust companies, including National Healthcare Corporation, Amedisys, Inc., Encompass Healthcare Corp., LTC Properties, Inc., Omega Healthcare Investors, Inc., Welltower Inc., Select Medical Holdings Corp., CareTrust REIT Inc. and National Health Investors, Inc.
• Based on these reviews, the Compensation Committee sets its annual retainers for outside directors and retainers to the chairpersons of each Board Committee at levels that we believe are comparable to the median cash compensation paid to directors of these companies.
• The company's mean score on the Five-Star Quality Rating System is 65.4%, which exceeds the national average score of 57.2%.
• The Company is fourth out of the largest skilled nursing organizations in quality measures and top 10 in 5-Star, long-stay measures and short-stay measures.

Related Party Transactions

• Clayton Christensen, brother of Executive Chairman, earned $996,061 in total cash compensation.
• Ryan Ross, brother-in-law of Chief Investment Officer, earned $229,305 in total compensation.
• Corwin Lewis, brother-in-law of Chief Operating Officer, earned $439,131 in total compensation.
• Jacque Holladay, mother-in-law of Chief Executive Officer, earned $120,661 in total compensation.

Stakeholder Impact

• The company's commitment to sustainable development practices and attention to social and governance priorities aims to enhance long-term value for stockholders.
• The company aims to have an enduring impact on the communities in which we live and work by embodying our Company's core values.
• The company is committed to the dignity and rights of all people, especially those whose lives may be impacted by our operations.
• The company is dedicated to prohibiting child labor, forced labor and discrimination while promoting the basic dignity of each resident, patient and employee at our facilities.
• The company supports our employee's occupational health and safety through providing sanitary facilities, abiding by all health and safety laws, ordinances and regulations governing facility uses and operations, and generally exceed acceptable levels of health and safety.
• The company has dedicated ourselves to providing and transforming dignified post-acute and long-term care and firmly believe accessibility to this care is a human right to everyone.
• The company's facilities aim to be the operation of choice within its local community by providing superior quality, affordable care.
• The company's employees are at the heart of our Company and we are committed to their health, professional development and workplace satisfaction.
• The company believes diversity is key to our success and is deeply committed to hiring and promoting inclusively, championing pay equity and increasing diverse representation at all levels.

Next Steps

• Stockholders are encouraged to vote on the proposals outlined in the proxy statement.
• The company intends to file the Certificate of Amendment with the Secretary of State of the State of Delaware promptly following receipt of authorization and approval by the stockholders at this Annual Meeting.

Key Dates

Keywords

proxy statement, annual meeting, board of directors, executive compensation, Deloitte & Touche, corporate governance, skilled nursing, healthcare, financial results, sustainability, ESG